.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Medtronic
Daiichi Sankyo
Deloitte
Cipla
UBS
Queensland Health
QuintilesIMS
McKinsey
Fish and Richardson

Generated: June 25, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 080935

« Back to Dashboard
NDA 080935 describes INH, which is a drug marketed by Novartis and is included in one NDA. Additional details are available on the INH profile page.

The generic ingredient in INH is isoniazid. There are five drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the isoniazid profile page.

Summary for NDA: 080935

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Antimycobacterials
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength300MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Cerilliant
Cipla
Dow
Colorcon
Mallinckrodt
Daiichi Sankyo
Fish and Richardson
Accenture
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot